公司资料
Talphera Inc 股价、新闻与催化剂
- 股票代码:
- TLPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.12 USD (-3.45%)
收盘价
最后更新: 2026年10月1日
40.2M USD
市值
股价为何变动
截至 2026年10月1日，TLPH 下跌 3.45%，收于 $1.12。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Talphera is a specialty pharmaceutical company focused on acute-care and pain management products. Its story is centered on hospital-oriented therapies and the challenge of commercial execution in acute care.
所在地与行业分类
Talphera is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and acute-care therapeutics.
商业模式特征
The company depends on product commercialization, hospital access, and financing discipline. Investors usually watch revenue, market adoption, and development milestones.
生物医药行业定位
Talphera occupies a small acute-care specialty-pharma niche. It is more commercial than many biotech names, but still very dependent on launch execution and access.
未来催化剂
- Tallahassee? / TLPH is the ticker for a biotech platform and the best fit is to treat it as a small-cap specialty-pharma name with catalysts around product execution and any strategic update. If the company keeps a clear commercial path, sentiment can improve quickly.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。